Results 201 to 210 of about 1,131,184 (349)
Extracellular vesicle (EV)‐packaged CDC37 are released from TMBhiCTLlo breast cancer cells with high CDC37 expression, and internalized into endo/phagosomes of dendritic cells (DCs). Within these compartments, CDC37 locked HSP90–antigen complex, preventing antigen release into the cytosol.
Ruxin Wang +10 more
wiley +1 more source
CD4+ T-lymphocytes in human saccular intracranial aneurysm walls are associated with aneurysm rupture. [PDF]
Firtser N +6 more
europepmc +1 more source
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance +17 more
wiley +1 more source
Development of Thymic Organoids Heterotopically to Educate and Induce T Lymphocytes. [PDF]
Wang X +5 more
europepmc +1 more source
Active Suppression of B Lymphocyte Maturation by Two Different Newborn T Lymphocyte Subsets [PDF]
Anne Durandy, Alain Fischer, C Griscelli
openalex +1 more source
Impaired anti‐tumor immunity is mediated by TREM2 + macrophages in non‐small cell lung cancer. TREM2 + macrophages prevent anti‐tumor immunity depending on the limitation of CD4 + T and NK cells. TREM2 promotes cholesterol efflux via ABCA1 to limit the production of CX3CL1 in macrophages.
Yunhan Wang +9 more
wiley +1 more source
Bexarotene signaling in human B and T lymphocytes induces gut-homing receptor expression. [PDF]
Kaiser S +6 more
europepmc +1 more source

